Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Ballantyne

Showing results (431-440 of 999) with videos related to

Pageof 100
Sort By:
JAMA Cardiology|April 7, 2024
Plozasiran (ARO-APOC3) for Severe Hypertriglyceridemia: The SHASTA-2 Randomized Clinical TrialDaniel Gaudet, Denes Pall, Gerald F Watts, et al.
JAMA|January 29, 2020
Association of Isolated Diastolic Hypertension as Defined by the 2017 ACC/AHA Blood Pressure Guideline With Incident Cardiovascular OutcomesJohn W McEvoy, Natalie Daya, Faisal Rahman, et al.
Magnetic Resonance Imaging|December 21, 2004
Tracking regression and progression of atherosclerosis in human carotid arteries using high-resolution magnetic resonance imagingGareth J Adams, Jennifer Greene, G Wesley Vick, et al.
Journal of the American College of Cardiology|June 18, 2013
Efficacy and safety of a novel dual modulator of adenosine triphosphate-citrate lyase and adenosine monophosphate-activated protein kinase in patients with hypercholesterolemia: results of a multicenter, randomized, double-blind, placebo-controlled, parallel-group trialChristie M Ballantyne, Michael H Davidson, Diane E Macdougall, et al.
Metabolic Syndrome and Related Disorders|April 21, 2015
Icosapent Ethyl (Eicosapentaenoic Acid Ethyl Ester): Effects Upon High-Sensitivity C-Reactive Protein and Lipid Parameters in Patients With Metabolic SyndromeHarold E Bays, Christie M Ballantyne, Rene A Braeckman, et al.
JAMA|September 8, 2005
Comparison of the instructional efficacy of Internet-based CME with live interactive CME workshops: a randomized controlled trialMichael Fordis, Jason E King, Christie M Ballantyne, et al.
Atherosclerosis|August 10, 2011
Differential effect of weight loss with low-fat diet or high-fat diet restriction on inflammation in the liver and adipose tissue of mice with diet-induced obesityQun Wang, Xiaoyuan Dai Perrard, Jerry L Perrard, et al.
Journal of the American Heart Association|November 9, 2016
25-Hydroxyvitamin D Levels and Markers of Subclinical Myocardial Damage and Wall Stress: The Atherosclerosis Risk in Communities StudyErin D Michos, Elizabeth Selvin, Jeffrey R Misialek, et al.
Clinical Biochemistry|March 16, 2016
Determinants of minimal elevation in high-sensitivity cardiac troponin T in the general populationJonathan Rubin, Kunihiro Matsushita, Mariana Lazo, et al.
The American Journal of Medicine|December 3, 2021
Association of Low-Density Lipoprotein Testing After an Atherosclerotic Cardiovascular Event with Subsequent Statin Adherence and IntensificationJamal S Rana, Salim S Virani, Howard H Moffet, et al.
Pageof 100

Showing results (431-440 of 999) with videos related to

Sort By:
Pageof 100
JAMA Cardiology|April 7, 2024
Plozasiran (ARO-APOC3) for Severe Hypertriglyceridemia: The SHASTA-2 Randomized Clinical TrialDaniel Gaudet, Denes Pall, Gerald F Watts, et al.
JAMA|January 29, 2020
Association of Isolated Diastolic Hypertension as Defined by the 2017 ACC/AHA Blood Pressure Guideline With Incident Cardiovascular OutcomesJohn W McEvoy, Natalie Daya, Faisal Rahman, et al.
Magnetic Resonance Imaging|December 21, 2004
Tracking regression and progression of atherosclerosis in human carotid arteries using high-resolution magnetic resonance imagingGareth J Adams, Jennifer Greene, G Wesley Vick, et al.
Journal of the American College of Cardiology|June 18, 2013
Efficacy and safety of a novel dual modulator of adenosine triphosphate-citrate lyase and adenosine monophosphate-activated protein kinase in patients with hypercholesterolemia: results of a multicenter, randomized, double-blind, placebo-controlled, parallel-group trialChristie M Ballantyne, Michael H Davidson, Diane E Macdougall, et al.
Metabolic Syndrome and Related Disorders|April 21, 2015
Icosapent Ethyl (Eicosapentaenoic Acid Ethyl Ester): Effects Upon High-Sensitivity C-Reactive Protein and Lipid Parameters in Patients With Metabolic SyndromeHarold E Bays, Christie M Ballantyne, Rene A Braeckman, et al.
JAMA|September 8, 2005
Comparison of the instructional efficacy of Internet-based CME with live interactive CME workshops: a randomized controlled trialMichael Fordis, Jason E King, Christie M Ballantyne, et al.
Atherosclerosis|August 10, 2011
Differential effect of weight loss with low-fat diet or high-fat diet restriction on inflammation in the liver and adipose tissue of mice with diet-induced obesityQun Wang, Xiaoyuan Dai Perrard, Jerry L Perrard, et al.
Journal of the American Heart Association|November 9, 2016
25-Hydroxyvitamin D Levels and Markers of Subclinical Myocardial Damage and Wall Stress: The Atherosclerosis Risk in Communities StudyErin D Michos, Elizabeth Selvin, Jeffrey R Misialek, et al.
Clinical Biochemistry|March 16, 2016
Determinants of minimal elevation in high-sensitivity cardiac troponin T in the general populationJonathan Rubin, Kunihiro Matsushita, Mariana Lazo, et al.
The American Journal of Medicine|December 3, 2021
Association of Low-Density Lipoprotein Testing After an Atherosclerotic Cardiovascular Event with Subsequent Statin Adherence and IntensificationJamal S Rana, Salim S Virani, Howard H Moffet, et al.
Pageof 100